Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
20
NCT00570089
Microvascular Coronary Disease In Women: Impact Of Ranolazine
Phase: Phase 2
Role: Collaborator
Start: Apr 30, 2007
Completion: Dec 31, 2009